Structure | Chemical Name | CAS | MF |
|
Heptanoic acid, 7-hydroxy-2,2-dimethyl-, ethyl ester
|
2280838-78-8
|
C11H22O3
|
|
Phevamine A
|
2280874-34-0
|
C22H39N7O2
|
|
(11bS)-2,6-Di-1-pyrenyl-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
|
2280936-20-9
|
C52H29O4P
|
|
m-PEG11-acid
|
2280998-74-3
|
C24H48O13
|
|
3-bromo-2-(4-fluorophenyl)indazole
|
2281761-79-1
|
C13H8BrFN2
|
|
mDPR(Boc)-Val-Cit-PAB
|
2281797-55-3
|
C30H43N7O9
|
|
19-Norlanosta-6,24-diene-9-carboxaldehyde, 3,5-dihydroxy-23-methoxy-, cyclic 9,5-(methyl acetal), [C(R),3β,5β,9β,10α,23S]-
|
2281872-79-3
|
C32H52O4
|
|
(R)-3-(Adamantan-1-yl)-1-(2-hydroxy-1-phenylethyl)-4,5-dihydro-1H-imidazol-3-ium hexafluorophosphate(V)
|
2281885-69-4
|
C21H29F6N2OP
|
|
7-(Tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-indole-2,3-dione
|
2281899-15-6
|
C14H16BNO4
|
|
N1,N2-bis(1-naphthalenylmethyl)ethanediamide
|
2281918-10-1
|
C24H20N2O2
|
|
Tofacitinib Impurity
|
2282653-53-4
|
C8H9ClN4
|
|
Oxazole, 2,2'-[2-[4-(1,1-dimethylethyl)phenyl]-1-[[4-(1,1-dimethylethyl)phenyl]methyl]ethylidene]bis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)-
|
2283330-44-7
|
C37H54N2O2
|
|
(Arg)9 TFA
|
2283335-13-5
|
C56H111F3N36O12
|
|
JAK/HDAC-IN-1
|
2284621-75-4
|
C19H21Cl2N7O2
|
|
Carbamic acid, N-[3-[(methylamino)methyl]cyclobutyl]-, 1,1-dimethylethyl ester
|
2285247-39-2
|
C11H22N2O2
|
|
LMP7-IN-1
|
2285330-15-4
|
C17H20BNO5
|
|
RTS-V5
|
2285346-31-6
|
C27H35N5O6
|
|
Ilaprazole Impurity 21
|
2285346-38-3
|
|
|
Ilaprazole Impurity 22
|
2285346-39-4
|
C18H16N4O
|
|
Ilaprazole Impurity 23
|
2285346-40-7
|
C19H18N4OS
|
|
Ilaprazole Impurity 5 (Ilaprazole Pyridine N-Oxide)
|
2285346-44-1
|
C19H18N4O3S
|
|
Ethyl (S)-1-((1-((4-((((4-nitrophenoxy)carbonyl) oxy)methyl)phenyl)amino)-1-oxo-5-ureidopenta n-2-yl)carbamoyl)cyclobutane-1-carboxylate
|
2285373-84-2
|
C28H33N5O10
|
|
3-Pyridinamine, 4-methyl-2-(1-methylethenyl)-
|
2286053-67-4
|
C9H12N2
|
|
Mycophenolate Mofetil EP Impurity C (Z-isomer)
|
2286278-51-9
|
C23H31NO7
|
|
8-Arm PEG-MAL
|
2286326-40-5
|
|
|
MBX4132
|
2286411-30-9
|
C18H15FN4O2
|
|
N-(9,9-dimethyl-9H-fluoren-3-yl)-9,9'-spirobi[fluoren]-2-amine
|
2286451-47-4
|
C40H29N
|
|
Voriconazole EP IMpurity E
|
2287183-06-4
|
C10H16O4S
|
|
(1-Ethyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)boronic acid
|
2287228-20-8
|
C6H8BF3N2O2
|
|
(1S)-1-(FURAN-3-YL)ETHAN-1-AMINE HYDROCHLORIDE
|
2287236-52-4
|
C6H10ClNO
|
|
(2R)-3-amino-2-methoxy-propan-1-ol
|
2287249-71-0
|
C4H11NO2
|
|
EP4 receptor antagonist 1
|
2287259-07-6
|
C23H21F3N4O3
|
|
3-(7-Fluoro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
|
2287267-33-6
|
C13H11FN2O3
|
|
2-(5-CHLORO-2-FLUOROPHENYL)PYRROLIDINE HYDROCHLORIDE
|
2287281-68-7
|
C10H12Cl2FN
|
|
1-(2-bromoethyl)-3,3-difluoropyrrolidine hydrobromide
|
2287283-91-2
|
C6H11Br2F2N
|
|
1,1-Cyclopropanedimethanamine, N1,N1-dimethyl-, hydrochloride (1:2)
|
2287287-03-8
|
C7H16N2.2ClH
|
|
4-bromo-2-(dimethylphosphoryl)benzonitrile
|
2287315-21-1
|
C9H9BrNOP
|
|
1H-3-Benzazepine, 7-bromo-2,3,4,5-tetrahydro-, hydrochloride (1:1)
|
2287316-81-6
|
C10H13BrClN
|
|
Carbamic acid, N-[(1R)-3-hydroxy-1-(methoxymethyl)propyl]-, 1,1-dimethylethyl ester
|
2287346-31-8
|
C10H21NO4
|
|
tert-butyl (2S,5S)-5-(hydroxymethyl)-2-methylpiperidine-1-carboxylate
|
2287346-60-3
|
C12H23NO3
|
|
(R)-tert-Butyl (1-(methoxy(methyl)amino)-1-oxopropan-2-yl)(methyl)carbamate
|
2287346-83-0
|
C11H22N2O4
|
|
2,4(1H,3H)-Pyrimidinedione, 6-(3-aminopropoxy)-1,3-dimethyl-
|
2287518-97-0
|
C9H15N3O3
|
|
methyl 3-(iodomethyl)bicyclo[1.1.1]pentane-1-carboxylate
|
2288708-53-0
|
C8H11IO2
|
|
2-(6-bromo-8-fluoro-3-quinolyl)ethoxy-tert-butyl-dimethyl-silane
|
2288708-54-1
|
C17H23BrFNOSi
|
|
N-(4-(Benzofuran-2-yl)-6-methylbenzo[d]thiazol-2-yl)-2-(2,3-dihydrobenzofuran-5-yl)acetamide
|
2288708-59-6
|
C26H20N2O3S
|
|
tert-Butyl 4-(1H-indazol-3-yl)-5,6-dihydropyridine-1(2H)-carboxylate
|
2288708-62-1
|
C17H21N3O2
|
|
1-Ethyl-7-phenyl-1,2,3,4-tetrahydroquinoline
|
2288708-68-7
|
C17H19N
|
|
4-(Bromomethyl)-2-methoxypyridine hydrobromide
|
2288708-87-0
|
C7H9Br2NO
|
|
1H-Indazole-5-methanamine, 1-(2,2,2-trifluoroethyl)-, hydrochloride (1:1)
|
2288708-90-5
|
C10H10F3N3.ClH
|
|
6-Fluoro-5-(tetrahydro-furan-3-yl)-nicotinic acid methyl ester
|
2288708-92-7
|
C11H12FNO3
|
|
2-fluorocyclobutanamine hydrochloride
|
2288709-22-6
|
C4H9ClFN
|
|
1-Pentylpiperazine hydrochloride
|
2288709-47-5
|
C9H21ClN2
|
|
1-Ethyl-7-(trifluoromethyl)-1,2,3,4-tetrahydroquinoline
|
2288709-48-6
|
C12H14F3N
|
|
tert-butyl (4-bromo-1,5-naphthyridin-3-yl)carbamate
|
2288709-49-7
|
C13H14BrN3O2
|
|
tert-butyl 2-carbamoylpyridin-3-ylcarbamate
|
2288709-59-9
|
C11H15N3O3
|
|
5-Benzofuranacetamide, N-[4-(2-furanyl)-6-methyl-2-benzothiazolyl]-2,3-dihydro-
|
2288709-60-2
|
C22H18N2O3S
|
|
2-Pyrazinecarboxaldehyde, 5-bromo-3-methoxy-
|
2288709-85-1
|
C6H5BrN2O2
|
|
Methyl 1-ethyl-1,2,3,4-tetrahydroquinoline-6-carboxylate
|
2288709-86-2
|
C13H17NO2
|
|
4-(Cyclopropylsulfonyl)-2-fluoropyridine
|
2288709-94-2
|
C8H8FNO2S
|
|
AZ32
|
2288709-96-4
|
C20H16N4O
|
|
Dimethyl 5-methylpyrimidine-4,6-dicarboxylate
|
2288710-03-0
|
C9H10N2O4
|
|
1H-Pyrrole-2-carboxylic acid, 3-(3,4-difluorophenyl)-5-methyl-, ethyl ester
|
2288710-15-4
|
C14H13F2NO2
|
|
(3-methylpyrazin-2-yl)methanamine dihydrochloride
|
2288710-30-3
|
C6H10ClN3
|
|
6-(2-(Methylsulfonyl)pyrimidin-5-yl)-N-(prop-2-yn-1-yl)hex-5-ynamide
|
2288710-39-2
|
C14H15N3O3S
|
|
4-Amino-2-(trifluoromethyl)benzaldehyde hydrochloride
|
2288710-41-6
|
C8H7ClF3NO
|
|
Benzenemethanol, 2-amino-5-[3-(1-piperidinyl)propoxy]-
|
2288710-47-2
|
C15H24N2O2
|
|
(4-(4-Methylthiazol-5-yl)phenyl)methanamine hydrochloride
|
2288710-66-5
|
C11H13ClN2S
|
|
2-Pyridinemethanol, 3,4-dimethoxy-, 1-oxide
|
2288740-66-7
|
C8H11NO4
|
|
Benzoic acid, 4,4',4'',4'''-(1,2,4,5-benzenetetrayltetra-2,1-ethenediyl)tetrakis-
|
2288850-51-9
|
C42H30O8
|
|
3-ethynyloxetan-3-amine
|
2289463-96-1
|
C5H7NO
|
|
MYCi361
|
2289690-31-7
|
C26H16ClF9N2O2
|
|
MYCi975
|
2289691-01-4
|
C25H16Cl2F6N2O2
|
|
Medetomidine Impurity 18
|
2289714-15-2
|
C15H20N2
|
|
Medetomidine Impurity 19
|
2289714-16-3
|
C15H20N2
|
|
Enpp-1-IN-1
|
2289728-58-9
|
C17H17N3O3S
|
|
4'-nitro-[1,1'-biphenyl]-3,5-dicarbaldehyde
|
2289758-94-5
|
C14H9NO4
|
|
5-(pyridin-4-yl)isophthalaldehyde
|
2289758-95-6
|
C13H9NO2
|
|
5-(thiophen-3-yl)isophthalaldehyde
|
2289758-96-7
|
C12H8O2S
|
|
3-chloro-[1,1'-biphenyl]-4,4'-dicarbaldehyde
|
2289758-97-8
|
C14H9ClO2
|
|
4,4',4''-(benzene-1,3,5-triyltris(ethyne-2,1-diyl))tribenzaldehyde
|
2289758-98-9
|
C33H18O3
|
|
(Z)-3-hydroxyicos-11-enoic acid
|
2290484-49-8
|
C20H38O3
|
|
Fluorinated VHL Spy Molecule 4
|
2290526-31-5
|
C15H16BrF3N2O3
|
|
Bractoppin
|
2290527-07-8
|
C25H23FN4O
|
|
2,7-dibromo-4,4,9,9-tetrahexyl-4,9-dihydro-s-indaceno[1,2-b:5,6-b']dithiophene
|
2290561-55-4
|
C40H56Br2S2
|
|
Levosimendan Impurity 16
|
2290570-69-1
|
C11H12N2O
|
|
Rosuvastatin Impurity
|
2290571-51-4
|
C22H26FN3O5S
|
|
Benzenesulfonamide, N-methyl-3-(1-methyl-1H-imidazol-4-yl)-4-[[4-(trifluoromethyl)phenyl]amino]-
|
2290608-13-6
|
C18H17F3N4O2S
|
|
1H-Pyrazolo[4,3-c]pyridine-7-carboxamide, 5-[(3,4-dichlorophenyl)methyl]-4,5-dihydro-4-oxo-1-(4-piperidinyl)-N-4-pyridinyl-
|
2290660-61-4
|
C24H22Cl2N6O2
|
|
GS-4361
|
2291164-02-6
|
C26H17F3N4O
|
|
METHYL 2-METHYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)NICOTINATE
|
2291165-13-2
|
C14H20BNO4
|
|
Fmoc-NH-PEG11-CH2CH2COOH
|
2291257-76-4
|
C41H63NO16
|
|
Trabectedin Intermediate
|
2291328-13-5
|
C43H45N3O6
|
|
2,6-Piperidinedione, 3-[1,3-dihydro-1-oxo-5-[1-(phenylmethyl)-4-piperidinyl]-2H-isoindol-2-yl]-
|
2291360-73-9
|
C25H27N3O3
|
|
3-[1-oxo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)-2,3-dihydro-1H-isoindol-2-yl]piperidine-2,6-di
one
|
2291363-98-7
|
C19H23BN2O5
|
|
2,6-Piperidinedione, 3-(1,3-dihydro-5-iodo-1-oxo-2H-isoindol-2-yl)-
|
2291364-01-5
|
C13H11IN2O3
|
|
Phenylephrine Impurity
|
2292095-11-3
|
C9H13NO2
|
|
4,4',4''-(9H-Carbazole-3,6,9-triyl)tris[benzoic acid]
|
2292116-92-6
|
C33H21NO6
|
|
Enalapril EP Impurity E Maleate
|
2292151-89-2
|
C26H32N2O5
|
|
Bletilloside A
|
2292159-89-6
|
C29H36O15
|
|
Duloxetine Impurity 8
|
2292353-17-2
|
C10H17NOS
|